AVANT Immunotherapeutics (Nasdaq: AVAN) is on the move today after data presented at ASCO showed that the company and Pfizer's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE